Monday, October 7, 2013

Cordlife: Attractive to private investors

Cordlife Group Ltd:
LAST CLOSE: S$1.285
FAIR VALUE: S$1.35 (adjusted)
Attractive to private investors

Proposed private placement raising up to $33.5 gross proceeds. Cordlife Group (CLGL) announced the proposed private placement of up to 26.8m new shares at an indicative price of $1.25 for each placement share. In total, the Group expects to raise net proceeds of $32.1m (or gross proceeds of $33.5m). The share placement will be carried out via a private placement of up to 17.8m shares and a direct subscription from five investors of up to 9.0m shares. The issue price of $1.25 represents a 3% discount from the last close price of $1.285 as at 2 October 2013.


73% of fresh capital deployed to funding its newly acquired operations. In the announcement, CLGL stated the use of $23.5m (73% of net proceeds) to fund and support the operations developed after the company’s IPO, which in our opinion would include the newly acquired subsidiaries in India, Philippines and Indonesia and its strategic alliance with StemLife Berhad. With the capital injection, the Group would be able to further align its business interests and pursue its growth potential. The remaining $8.6m will be utilized for general working capital purposes.

Cordlife CEO steps down from the Board of China Cord Blood Corp (CCBC). Mr Jeremy Yee, Cordlife Group CEO was previously the independent non-executive director on the board of CCBC. Wef from 27 September 2013, Mr Yee has stepped down from board duties to focus on CLGL’s expansion in India, Philippines and Indonesia. CLGL’s investment in CCBC will be accounted for as a financial asset going forward.

FY14F EPS lowered by 21% to 3.3 cents due to dilution impact and accounting reclassification of CCB. Assuming a full subscription of the private placement, we lower FY14F/15F PAT by approximately $2m and $4m respectively and henceforth EPS adjusts to 3.3 cents and 2.8 cents accordingly.

Maintain HOLD with a TP of $1.35. We adjust our DCF-derived TP to $1.35, as a result of the dilution impact from the capital injection. We view the private placement as a positive development as the company is in a better capacity to monetize the growth potential from the earnings accretive acquisitions.


Source/Extract/Excerpts/来源/转贴/摘录: AmFraser-Research,
Publish date: 03/10/13

No comments:

Post a Comment

Warren E. Buffett(沃伦•巴菲特)
Be fearful when others are greedy, and be greedy when others are fearful
别人贪婪时我恐惧, 别人恐惧时我贪婪
投资只需学好两门课: 一,是如何给企业估值,二,是如何看待股市波动
吉姆·罗杰斯(Jim Rogers)
“错过时机”胜于“搞错对象”:不会全军覆没!”
做自己熟悉的事,等到发现大好机会才投钱下去

乔治·索罗斯(George Soros)

“犯错误并没有什么好羞耻的,只有知错不改才是耻辱。”

如果操作过量,即使对市场判断正确,仍会一败涂地。

李驰(中国巴菲特)
高估期间, 卖对, 不卖也对, 买是错的。
低估期间, 买对, 不买也是对, 卖是错的。

Tan Teng Boo


There’s no such thing as defensive stocks.Every stock can be defensive depending on what price you pay for it and what value you get,
冷眼(冯时能)投资概念
“买股票就是买公司的股份,买股份就是与陌生人合股做生意”。
合股做生意,则公司股份的业绩高于一切,而股票的价值决定于盈利。
价值是本,价格是末,故公司比股市重要百倍。
曹仁超-香港股神/港股明灯
1.有智慧,不如趁势
2.止损不止盈
成功者所以成功,是因为不怕失败!失败者所以失败,是失败后不再尝试!
曾淵滄-散户明灯
每逢灾难就是机会,而是在灾难发生时贱价买股票,然后放在一边,耐性地等灾难结束
  • Selected Indexes 52 week range

  • Margin of Safety

    Investment Clock

    World's First Interactive Investment Clock